Allon Therapeutics, Inc.
Company provides pipeline update, completes preclinical studies for AL-108
Published in Law and Health Weekly, January 1st, 2005
In the quarter, the company completed a successful public equity financing and continued progress in its drug development program remaining on schedule to file an Investigational New Drug (IND) application by the end of 2004. This IND will seek United States Food and Drug Administration (FDA) approval to evaluate the company's lead product AL-108 in human clinical trials.
Gordon McCauley, president of Allon, said the company has scheduled phase I clinical trials to begin during Q1 2005, subject to FDA approval of the IND. The company...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Biotechnology Industry Organization
Biotech group urges Congress to keep patent fees at PTO - Institute of Immunology, Zagreb
Assay to measure Fc function of immunoglobulin preparations developed - Intarcia Therapeutics Inc.
Pharmaceutical company announces new appointments to board of directors - Legal Issues
Merck appoints committee to review company actions on Vioxx - Medical Ethics
New center to study medical ethics in the care of children - Medicare
Drug card enrollment falls short - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
